G. Bhat

发表

The effect of androgen deprivation therapy on fasting serum lipid and glucose parameters.

J. Manola, G. Bubley, J. Yannucci, 2006, The Journal of urology.

CaRES (Contrast Echocardiography Registry for Safety Surveillance): a prospective multicenter study to evaluate the safety of the ultrasound contrast agent definity in clinical practice.

Masood Ahmad, F. Villanueva, R. Weiss, 2012, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

p 66 Shc Tumor Levels Show a Strong Prognostic Correlation with Disease Outcome in Stage IIAColon Cancer

S. Grossman, C. Hsieh, S. Lyle, 2007 .

A multicenter, prospective study to evaluate the use of contrast stress echocardiography in early menopausal women at risk for coronary artery disease: trial design and baseline findings.

P. Pellikka, P. Best, S. Mulvagh, 2013, Journal of women's health.

Characterizing the belinostat response in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma

S. Horwitz, O. O’Connor, Helen Ma, 2020, Leukemia & lymphoma.

A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T‐cell lymphoma

R. Advani, E. Jacobsen, L. F. Allen, 2015, British journal of haematology.

QapzolaTM) Intravesical Instillation Post Transurethral Resection of Bladder Tumors for the Treatment of Low-risk Non-Muscle Invasive Bladder Cancer

J. Witjes, M. Soloway, S. Leu, 2018 .

Poziotinib in Non–Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutations After Prior Therapies: ZENITH20-2 Trial

M. Socinski, J. Heymach, X. Le, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of the efficacy of sitagliptin with pioglitazone on dexamethasone-induced hepatic steatosis, dyslipidemia, and hyperglycemia in albino rats -

K. Vinodraj, G. Bhat, D. Rajesh, 2015 .

36MO Safety, tolerability and preliminary efficacy of poziotinib with twice daily strategy in EGFR/HER2 Exon 20 mutant non-small cell lung cancer

M. Socinski, E. Haura, J. Molina, 2021 .

Poziotinib shows activity and durability of responses in subgroups of previously treated EGFR exon 20 NSCLC patients.

M. Socinski, X. Le, J. Clarke, 2020 .

High-Dose Vincristine Sulfate Liposome Injection, for Advanced, Relapsed, or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in an Adolescent and Young Adult Subgroup of a Phase 2 Clinical Trial.

G. Schiller, S. Coutre, L. Damon, 2018, Journal of adolescent and young adult oncology.

A comparison of eflapegrastim to pegfilgrastim in the management of chemotherapy‐induced neutropenia in patients with early‐stage breast cancer undergoing cytotoxic chemotherapy (RECOVER): A Phase 3 study

I. Láng, L. Schwartzberg, S. Chawla, 2020, Cancer medicine.

Eflapegrastim, a Long‐Acting Granulocyte‐Colony Stimulating Factor for the Management of Chemotherapy‐Induced Neutropenia: Results of a Phase III Trial

L. Schwartzberg, I. Mehmi, S. Chawla, 2020, The oncologist.

Safe and Effective Treatment of Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL) and Low Baseline Platelet Counts with Belinostat

K. Savage, P. Zinzani, S. Horwitz, 2014 .

Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study.

K. Savage, S. Horwitz, L. F. Allen, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I clinical trial of the effect of belinostat on the pharmacokinetics and pharmacodynamics of warfarin

N. Agarwal, Sunil Sharma, Sumati Gupta, 2016, Cancer Chemotherapy and Pharmacology.

p66 Shc Tumor Levels Show a Strong Prognostic Correlation with Disease Outcome in Stage IIA Colon Cancer

S. Grossman, C. Hsieh, S. Lyle, 2007, Clinical Cancer Research.

A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation.

P. Hari, N. Callander, L. F. Allen, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A phase I study to determine the pharmacokinetics and urinary excretion of belinostat and metabolites in patients with advanced solid tumors

N. Agarwal, Sunil Sharma, Sumati Gupta, 2016, Cancer Chemotherapy and Pharmacology.

Belinostat in combination with standard cyclophosphamide, doxorubicin, vincristine and prednisone as first-line treatment for patients with newly diagnosed peripheral T-cell lymphoma

S. de Vos, Y. Oki, C. Deng, 2021, Experimental Hematology & Oncology.

Management of Mucositis with the Use of Leucovorin As Adjunct to Pralatrexate in Treatment of Peripheral T-Cell Lymphomas (PTCL) — Results from a Prospective Multicenter Phase 2 Clinical Trial

S. Dakhil, M. Shinohara, J. Zain, 2018, Blood.

Pralatrexate in Combination with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Previously Untreated Patients with Peripheral T-Cell Lymphoma (PTCL): A Phase 1 Dose-Escalation Study

Y. Oki, S. Barta, A. Shustov, 2017 .

Results of a Phase II Study of Propylene Glycol (PG)-Free, Captisol-Enabled Melphalan Conditioning for Autologous Hematopoietic Stem Cell Transplantation (AHCT) in Patients with Multiple Myeloma (MM)

P. Hari, N. Callander, L. F. Allen, 2015 .

Abarelix for injectable suspension: first-in-class gonadotropin-releasing hormone antagonist for prostate cancer.

F. Debruyne, M. Garnick, G. Bhat, 2006, Future oncology.